Showing results (901-910 of 1,906) with videos related to
Sort By:
Pageof 191
Current Neuropharmacology|February 8, 2021
Recent Discussions on Dopamine Supersensitivity Psychosis: Eight Points to Consider When Diagnosing Treatment-Resistant SchizophreniaNobuhisa Kanahara, Hiroshi Kimura, Yasunori Oda, et al.Current Neuropharmacology|January 17, 2022
The Role of High Mobility Group Box 1 (HMGB1) in Neurodegeneration: A Systematic ReviewFathimath Zaha Ikram, Alina Arulsamy, Thaarvena Retinasamy, et al.Current Neuropharmacology|December 16, 2021
The Orexin System: A Potential Player in the Pathophysiology of Absence EpilepsyRoberta Celli, Gilles Van LuijtelaarCurrent Neuropharmacology|January 19, 2022
Neuroinflammation: The Role of Anthocyanins as NeuroprotectantsOtilia J F Banji, David Banji, Hafiz A Makeen, et al.Current Neuropharmacology|January 19, 2022
Targeting PI3K by Natural Products: A Potential Therapeutic Strategy for Attention-deficit Hyperactivity DisorderTayebeh Noori, Mousa Sahebgharani, Antoni Sureda, et al.Current Neuropharmacology|September 3, 2011
Decreases in brain reward function reflect nicotine- and methamphetamine-withdrawal aversion in ratsHisatsugu Miyata, Michio Itasaka, Naofumi Kimura, et al.Current Neuropharmacology|September 3, 2011
MOP Reduction During Long-Term Methamphetamine Withdrawal was Restored by Chronic Post-Treatment with FluoxetineH Yamamoto, Y Takamatsu, K Imai, et al.Current Neuropharmacology|September 3, 2011
Methamphetamine induces striatal cell death followed by the generation of new cells and a second round of cell death in miceI K Tulloch, L Afanador, J Zhu, et al.Current Neuropharmacology|September 3, 2011
Identifying changes in the synaptic proteome of cirrhotic alcoholic superior frontal gyrusN Etheridge, R D Mayfield, R A Harris, et al.Current Neuropharmacology|September 3, 2011
No Association Between GRM3 and Japanese Methamphetamine-Induced PsychosisTomoko Tsunoka, Taro Kishi, Masashi Ikeda, et al.Pageof 191